Vaxcyte, Inc. PCVX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s operating lease liabilities (total)?
- Vaxcyte, Inc. (PCVX) reported operating lease liabilities (total) of $116.3M in Q1 2026.
- How has Vaxcyte, Inc.'s operating lease liabilities (total) changed year-over-year?
- Vaxcyte, Inc.'s operating lease liabilities (total) increased by 33.5% year-over-year, from $87.11M to $116.3M.
- What is the long-term trend for Vaxcyte, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s operating lease liabilities (total) has grown at a 165.0% compound annual growth rate (CAGR), from $900K to $117.58M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.